INIS
cancer
100%
patients
87%
radiotherapy
74%
breasts
33%
tumors
26%
doses
25%
risks
23%
lung cells
22%
data
21%
radiations
20%
therapy
19%
irradiation
17%
comparative evaluations
17%
volume
16%
lungs
15%
protons
13%
diseases
13%
reviews
13%
planning
13%
learning
13%
prediction
12%
brain
12%
surgery
12%
images
11%
toxicity
11%
carcinomas
11%
metastases
11%
computerized tomography
10%
prostate
10%
guidelines
9%
validation
9%
tissues
8%
netherlands
8%
brachytherapy
8%
computed tomography
8%
rectum
7%
performance
7%
management
7%
phantoms
6%
quality of life
6%
organs
6%
evaluation
6%
implementation
6%
assessments
6%
simulation
5%
lymph nodes
5%
positron computed tomography
5%
beams
5%
machine learning
5%
recommendations
5%
levels
5%
optimization
5%
clinical trials
5%
information
5%
quality assurance
5%
range
5%
combined therapy
5%
esophagus
5%
Medicine and Dentistry
Radiation Therapy
62%
Breast Cancer
21%
Non Small Cell Lung Cancer
18%
Neoplasm
16%
Disease
10%
Recurrent Disease
9%
Quality of Life
9%
Lung Cancer
9%
Treatment Planning
8%
Proton Therapy
8%
Malignant Neoplasm
8%
Head and Neck Cancer
7%
Chemoradiotherapy
6%
Brachytherapy
6%
Prostate Cancer
6%
Systemic Therapy
6%
Systematic Review
6%
Dosimetry
6%
Overall Survival
6%
Arm
5%
Recurrence Risk
5%
Computer Assisted Tomography
5%
Mastectomy
5%
Immunotherapy
5%
Uterine Cancer
5%
Clinical Trial
5%
Keyphrases
Radiotherapy
32%
Radiation Therapy
19%
Breast Cancer
12%
Netherlands
9%
Head-and-neck Cancer
8%
Non-small Cell Lung Cancer (NSCLC)
7%
Quality of Life
6%
Stage III Non-small Cell Lung Cancer
6%
Proton Therapy
6%
Dutch
6%
Treatment Planning
6%
Lung Cancer
5%
Mastectomy
5%
Tumor
5%
Colorectal Cancer
5%
Endometrial Cancer
5%
European Society
5%
Deep Learning
5%
Overall Survival
5%